Our paper provides a complete evaluation of recombinant human IL-1A, covering its manufacture processes, biological activities, and potential therapeutic uses. We discuss the existing understanding of this cytokine in terms of its configuration, function in immune reactions, and emerging research demonstrating its utility in multiple disease models